The hypertrophied myocardium accumulates the MB-creatine kinase isozyme

European Heart Journal
|December 1, 1984
PubMed

Insights

Changes in heart creatine kinase isozymes occur during myocardial hypertrophy. Fetal creatine kinase increases in compensated hypertrophy, while mitochondrial creatine kinase decreases during the transition to heart failure.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Myocardial hypertrophy is a significant cardiac adaptation.
  • The creatine kinase system plays a crucial role in cellular energy metabolism.
  • Understanding alterations in this system during hypertrophy is vital for cardiac health.

Purpose of the Study:

  • To investigate changes in the creatine kinase system in hypertrophied hearts.
  • To determine if isozyme distribution shifts with cardiac hypertrophy and failure.

Main Methods:

  • Induction of myocardial hypertrophy in dogs and rats via various overload models.
  • Analysis of creatine kinase isozyme distribution and activity.
  • P-31 NMR magnetization transfer experiments to assess reaction flux.

Main Results:

  • Total creatine kinase activity remained largely unchanged.
  • Significant accumulation of MB-creatine kinase in hypertrophied ventricles of dogs and rats.
  • A strong correlation (r ≈ 0.92) between increased fetal creatine kinase isozymes and ventricular weight increase in spontaneously hypertensive rats.
  • A 50% reduction in mitochondrial creatine kinase activity during the transition to heart failure in spontaneously hypertensive rats.
  • P-31 NMR indicated a 3-fold lower flux through the creatine kinase reaction in failing hearts.

Conclusions:

  • Hypertrophied hearts exhibit altered creatine kinase isozyme distribution.
  • Increased fetal-type creatine kinase isozymes characterize compensated hypertrophy.
  • Decreased mitochondrial creatine kinase activity signifies the transition to heart failure.

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...